Abbott Laboratories (ABT) Q3 2013 Earnings Results

Abbott Labs Beats on EPS, Stock Up 6.5%

Abbott Labs' earnings report shows a positive surprise in EPS, which likely contributed to the 6.5% increase in stock price. Investors may view the EPS beat as a sign of operational strength, even though no revenue figures or guidance were provided. The management's cautious optimism suggests they are focused on navigating challenges ahead.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.55	N/A	+7.21%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook regarding earnings performance. However, they did not provide specific guidance for future quarters.

Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.

They emphasized their focus on maintaining operational efficiency.

Abbott Labs Beats on EPS, Stock Up 6.5%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Beats on EPS, Stock Up 6.5%

Key numbers

Management commentary